Clinical trial
Clonazepam and Paroxetine for Rapid Treatment of Post-Traumatic Stress Disorder
NCT00025740 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00025740 |
|---|---|
| Title | Clonazepam and Paroxetine for Rapid Treatment of Post-Traumatic Stress Disorder |
| Official title | Combined Treatment With a Benzodiazepine (Clonazepam) and a Selective Serotonin Reuptake Inhibitor (Paroxetine) for Rapid Treatment of Posttraumatic Stress Disorder (PTSD) |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Post Traumatic Stress Disorder |
| Intervention type | Drug |
| Interventions | clonazepam and paroxetine |
| Enrollment | 78 |
| Start date | Oct 1, 2001 |
| Completion | Aug 1, 2004 |
| First posted | Oct 17, 2001 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: